↓ Skip to main content

Dove Medical Press

Efficacy and Safety of the CFTR Potentiator Icenticaftor (QBW251) in COPD: Results from a Phase 2 Randomized Trial

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, October 2020
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (63rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter
1 X user
wikipedia
1 Wikipedia page

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
50 Mendeley
Title
Efficacy and Safety of the CFTR Potentiator Icenticaftor (QBW251) in COPD: Results from a Phase 2 Randomized Trial
Published in
International Journal of Chronic Obstructive Pulmonary Disease, October 2020
DOI 10.2147/copd.s257474
Pubmed ID
Authors

Steven M Rowe, Ieuan Jones, Mark T Dransfield, Nazmul Haque, Stephen Gleason, Katy A Hayes, Kenneth Kulmatycki, Denise P Yates, Henry Danahay, Martin Gosling, David J Rowlands, Sarah S Grant

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 50 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 12%
Student > Ph. D. Student 5 10%
Unspecified 3 6%
Student > Postgraduate 3 6%
Student > Doctoral Student 2 4%
Other 6 12%
Unknown 25 50%
Readers by discipline Count As %
Medicine and Dentistry 10 20%
Biochemistry, Genetics and Molecular Biology 3 6%
Unspecified 3 6%
Nursing and Health Professions 3 6%
Agricultural and Biological Sciences 2 4%
Other 4 8%
Unknown 25 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 June 2021.
All research outputs
#7,361,749
of 25,387,668 outputs
Outputs from International Journal of Chronic Obstructive Pulmonary Disease
#863
of 2,578 outputs
Outputs of similar age
#155,547
of 432,252 outputs
Outputs of similar age from International Journal of Chronic Obstructive Pulmonary Disease
#20
of 55 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 2,578 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.5. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 432,252 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 55 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.